These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 30942794)
1. Discovery of high in vitro and in vivo antitumor activities of organometallic ruthenium(ii)-arene complexes with 5,7-dihalogenated-2-methyl-8-quinolinol. Meng T; Qin QP; Chen ZL; Zou HH; Wang K; Liang FP Dalton Trans; 2019 Apr; 48(16):5352-5360. PubMed ID: 30942794 [TBL] [Abstract][Full Text] [Related]
2. Development of novel ruthenium(II)-arene complexes displaying potent anticancer effects in glioblastoma cells. Kumar P; Mondal I; Kulshreshtha R; Patra AK Dalton Trans; 2020 Oct; 49(38):13294-13310. PubMed ID: 32936191 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes. Vock CA; Scolaro C; Phillips AD; Scopelliti R; Sava G; Dyson PJ J Med Chem; 2006 Sep; 49(18):5552-61. PubMed ID: 16942028 [TBL] [Abstract][Full Text] [Related]
5. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity. Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447 [TBL] [Abstract][Full Text] [Related]
6. Monofunctional dimetallic Ru(η6-arene) complexes inhibit NOTCH1 signaling pathway and synergistically enhance anticancer effect in combination with cisplatin or vitamin C. Wang N; Ali A; Liu Z; Chi H; Lv Z; Zhao X; Zhang Z; Hao H; Zhang Y; Rahman FU Eur J Med Chem; 2023 Oct; 258():115536. PubMed ID: 37295260 [TBL] [Abstract][Full Text] [Related]
10. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties. Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819 [TBL] [Abstract][Full Text] [Related]
12. Insights into the antineoplastic activity and mechanisms of action of coumarin-coordinated 8-hydroxyquinoline ruthenium(II/III) compounds. Du LQ; Yang Y; Ruan L; Sun S; Mo DY; Cai JY; Liang H; Shu S; Qin QP J Inorg Biochem; 2024 Oct; 259():112659. PubMed ID: 38976937 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and intramolecular and interionic structural characterization of half-sandwich (arene)ruthenium(II) derivatives of bis(pyrazolyl)alkanes. Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Di Nicola C; Macchioni A; Zuccaccia D; Monari M; Piccinelli F Inorg Chem; 2008 Dec; 47(24):11593-603. PubMed ID: 18998632 [TBL] [Abstract][Full Text] [Related]
17. Amberlite IR-120 (H) mediated "on water" synthesis of fluorescent Ruthenium(II)-arene 8-hydroxyquinoline complexes for cancer therapy and live cell imaging. Mondal A; De S; Maiti S; Sarkar B; Sk AK; Jacob R; Moorthy A; Paira P J Photochem Photobiol B; 2018 Jan; 178():380-394. PubMed ID: 29195215 [TBL] [Abstract][Full Text] [Related]
18. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling. Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320 [TBL] [Abstract][Full Text] [Related]
19. The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity. Caruso F; Pettinari R; Rossi M; Monti E; Gariboldi MB; Marchetti F; Pettinari C; Caruso A; Ramani MV; Subbaraju GV J Inorg Biochem; 2016 Sep; 162():44-51. PubMed ID: 27293144 [TBL] [Abstract][Full Text] [Related]
20. Ruthenium(ii) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies. Bhattacharyya S; Purkait K; Mukherjee A Dalton Trans; 2017 Jul; 46(26):8539-8554. PubMed ID: 28638907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]